Search - tctmd.com

Displaying 141 - 160 of 2498

Sort: Relevancy | Date

Presentation TCT 2016

Treatment of a Rare Complication in the 21st Century

Presenter: Wojtek Wojakowski, Balint Kittka

October 31, 2016

Presentation TCT 2016

Improving Clinical Science: Priorities and Methods of Clinical Trials in Cardiovascular Regenerative Medicine

Presenter: Emerson C. Perin, Bernard J. Gersh

October 31, 2016

Presentation TCT 2016

Cells at the Moment of Truth: Findings From Meta-analysis and Systematic Reviews

Presenter: Emerson C. Perin, Mariann Gyöngyösi

October 31, 2016

Presentation TCT 2016

Beyond Cells: Cardiac Gene Therapy In Perspective

Presenter: Emerson C. Perin, Marc S. Penn

October 31, 2016

Presentation TCT 2016

New Sights from CHART -1 at 1 Year: Relationship of outcomes to baseline biomarkers and treatment intensity

Presenter: Emerson C. Perin, Jozef Bartunek

October 31, 2016

Presentation TCT 2016

How Did I Treat This Case?

Presenter: Jun-Jack Cheng, Gary S. Mintz, Chiung Jen Wu, Wen-Lieng Lee

October 31, 2016

Presentation TCT 2016

Cells Alone Work: Lessons From Recent Clinical Trials

Presenter: Emerson C. Perin

October 31, 2016

Presentation TCT 2016

Case 3: Heavily Calcified Vessel

Presenter: Jun-Jack Cheng, Gary S. Mintz, Chiung Jen Wu, Wen-Lieng Lee

October 31, 2016

Presentation TCT 2016

How Did I Treat This Case?

Presenter: Jun-Jack Cheng, Gary S. Mintz, Chiung Jen Wu, Hsiu-Yu Fang

October 31, 2016

Presentation TCT 2016

Case 2: Complex PCI

Presenter: Jun-Jack Cheng, Gary S. Mintz, Chiung Jen Wu, Hsiu-Yu Fang

October 31, 2016

Presentation TCT 2016

When Everything Has Disappeared: Role of Cell-Based Engineered Tissue and Organ Transplantation.

Presenter: Timothy D. Henry, Amit N. Patel, Doris A. Taylor

October 31, 2016

Presentation TCT 2016

TCT 260: Outcomes of Chronic Total Occlusion PCI in Patients with Diabetes Insights from the OPEN CTO Registry

Presenter: Kevin J. Beatt, Frederick Feit

October 31, 2016

Presentation TCT 2016

When Cells are Not Enough: Role of Cellular and Non-Cellular Injectable Biomaterials

Presenter: Timothy D. Henry, Amit N. Patel

October 31, 2016

Presentation TCT 2016

TCT 262: Clinical Outcomes of Deferred Revascularization Using Fractional Flow Reserve in Patients With and Without Diabetes Mellitus

Presenter: Kevin J. Beatt, Frederick Feit

October 31, 2016

Presentation TCT 2016

Improving Translational Science In Cardiac Regenerative Medicine. Utility of Animal Models

Presenter: Timothy D. Henry, Amit N. Patel, Steven A.J. Chamuleau

October 31, 2016

Presentation TCT 2016

TCT 263: Impact of Diabetes on Clinical Outcomes in Patients Undergoing Unprotected Left Main Percutaneous Coronary Intervention with Drug-Eluting Stents

Presenter: Kevin J. Beatt, Frederick Feit

October 31, 2016

Presentation TCT 2016

TCT 261: Impact of Diabetes on Clinical Outcomes after Revascularization with Sirolimus-Eluting and Birolimus-Eluting Stents with Biodegradable Polymer. From the SORT OUT VII Trial

Presenter: Kevin J. Beatt, Frederick Feit

October 31, 2016

Presentation TCT 2016

Obstacles for Clinical Research: Perspectives From Industry

Presenter: Emerson C. Perin, Ricardo Sanz-Ruiz, Warren Sherman

October 31, 2016

Egypt Responds: How Would I Have Treated This Case in My Cath Lab?

Presentation TCT 2016

Egypt Presents: A Case of a Challenging Bifurcation Intervention: How Did I Treat?

Presenter: Mohammad Al-Mutairi, Ricardo Lluberas, Ahmed Magdy, Jorge Villegas, Robaayah Zambahari, Sameh Shaheen

October 31, 2016

Presentation TCT 2016

Malaysia Responds: How Would I Have Treated This Case in My Cath Lab?

Presenter: Mohammad Al-Mutairi, Ricardo Lluberas, Ahmed Magdy, Jorge Villegas, Robaayah Zambahari

October 31, 2016

Advertisement

Treatment of a Rare Complication in the 21st Century

Improving Clinical Science: Priorities and Methods of Clinical Trials in Cardiovascular Regenerative Medicine

Cells at the Moment of Truth: Findings From Meta-analysis and Systematic Reviews

Beyond Cells: Cardiac Gene Therapy In Perspective

New Sights from CHART -1 at 1 Year: Relationship of outcomes to baseline biomarkers and treatment intensity

How Did I Treat This Case?

Cells Alone Work: Lessons From Recent Clinical Trials

Case 3: Heavily Calcified Vessel

How Did I Treat This Case?

Case 2: Complex PCI

When Everything Has Disappeared: Role of Cell-Based Engineered Tissue and Organ Transplantation.

TCT 260: Outcomes of Chronic Total Occlusion PCI in Patients with Diabetes Insights from the OPEN CTO Registry

When Cells are Not Enough: Role of Cellular and Non-Cellular Injectable Biomaterials

TCT 262: Clinical Outcomes of Deferred Revascularization Using Fractional Flow Reserve in Patients With and Without Diabetes Mellitus

Improving Translational Science In Cardiac Regenerative Medicine. Utility of Animal Models

TCT 263: Impact of Diabetes on Clinical Outcomes in Patients Undergoing Unprotected Left Main Percutaneous Coronary Intervention with Drug-Eluting Stents

TCT 261: Impact of Diabetes on Clinical Outcomes after Revascularization with Sirolimus-Eluting and Birolimus-Eluting Stents with Biodegradable Polymer. From the SORT OUT VII Trial

Obstacles for Clinical Research: Perspectives From Industry

Egypt Presents: A Case of a Challenging Bifurcation Intervention: How Did I Treat?

Malaysia Responds: How Would I Have Treated This Case in My Cath Lab?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content